Resmed Inc. buy JPMorgan Chase & Co.
Start price
15.04.26
/
50%
€194.25
Target price
15.04.27
-
Performance (%)
-6.02%
Price
14:05
€182.55
Summary
This prediction is currently active. With a performance of -6.02%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 15.04.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 6.519% | 6.519% |
| iShares Core DAX® | 2,59 % | 2,47 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % |
| iShares S&P 500 | -0,37 % | -1,22 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat